179 related articles for article (PubMed ID: 35614183)
21. Differential Song Deficits after Lentivirus-Mediated Knockdown of FoxP1, FoxP2, or FoxP4 in Area X of Juvenile Zebra Finches.
Norton P; Barschke P; Scharff C; Mendoza E
J Neurosci; 2019 Dec; 39(49):9782-9796. PubMed ID: 31641053
[TBL] [Abstract][Full Text] [Related]
22. PRMT5 and FOXP1 expression profile in invasive breast cancer patients undergoing neoadjuvant chemotherapy.
Su H; Liu Y; Zhang C; Yu T; Niu Y
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):142-145. PubMed ID: 32415941
[TBL] [Abstract][Full Text] [Related]
23. NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
Lu J; Hu F; Zhou Y
Biomed Res Int; 2021; 2021():9025481. PubMed ID: 33564687
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of the Immune-Oncology Targets and Immune Infiltrates of
Zhang X; Shen L; Cai R; Yu X; Yang J; Wu X; Zhu Y; Liu X
Front Cell Dev Biol; 2021; 9():686675. PubMed ID: 34277627
[TBL] [Abstract][Full Text] [Related]
25. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
26. Exploring the role CD163-labeled TAMs and FOXP3-labeled Tregs in different types of breast cancer: Reflections and putative benefits.
Shash LS; M Kamal KA; Abd Raboh NM
Indian J Pathol Microbiol; 2021; 64(1):28-37. PubMed ID: 33433406
[TBL] [Abstract][Full Text] [Related]
27. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
Zuo T; Liu R; Zhang H; Chang X; Liu Y; Wang L; Zheng P; Liu Y
J Clin Invest; 2007 Dec; 117(12):3765-73. PubMed ID: 18008005
[TBL] [Abstract][Full Text] [Related]
28. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer.
Chu PY; Tzeng YT; Tsui KH; Chu CY; Li CJ
Aging (Albany NY); 2022 Mar; 14(5):2252-2267. PubMed ID: 35247251
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
Xu Y; Lan S; Zheng Q
Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
[TBL] [Abstract][Full Text] [Related]
31. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.
Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M
Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy.
Tsiatas M; Kalogeras KT; Manousou K; Wirtz RM; Gogas H; Veltrup E; Zagouri F; Lazaridis G; Koutras A; Christodoulou C; Pentheroudakis G; Petraki C; Bafaloukos D; Pectasides D; Kosmidis P; Samantas E; Karanikiotis C; Papakostas P; Dimopoulos MA; Fountzilas G
Cancer Med; 2018 Oct; 7(10):5066-5082. PubMed ID: 30240146
[TBL] [Abstract][Full Text] [Related]
33. FOXP3 expression is related to high Ki-67 index and poor prognosis in lymph node-positive breast cancer patients.
Kim MH; Koo JS; Lee S
Oncology; 2013; 85(2):128-36. PubMed ID: 23948758
[TBL] [Abstract][Full Text] [Related]
34. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.
Ortiz-Martínez F; Gutiérrez-Aviñó FJ; Sanmartín E; Pomares-Navarro E; Villalba-Riquelme C; García-Martínez A; Lerma E; Peiró G
Exp Mol Pathol; 2016 Jun; 100(3):460-8. PubMed ID: 27118257
[TBL] [Abstract][Full Text] [Related]
35. ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration.
Wang J; Zhang X; Li J; Ma X; Feng F; Liu L; Wu J; Sun C
Aging (Albany NY); 2020 Nov; 13(1):351-363. PubMed ID: 33234738
[TBL] [Abstract][Full Text] [Related]
36. FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.
De Silva P; Garaud S; Solinas C; de Wind A; Van den Eyden G; Jose V; Gu-Trantien C; Migliori E; Boisson A; Naveaux C; Duvillier H; Craciun L; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
EBioMedicine; 2019 Jan; 39():226-238. PubMed ID: 30579865
[TBL] [Abstract][Full Text] [Related]
37. Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.
Rayoo M; Yan M; Takano EA; Bates GJ; Brown PJ; Banham AH; Fox SB
J Clin Pathol; 2009 Oct; 62(10):896-902. PubMed ID: 19622517
[TBL] [Abstract][Full Text] [Related]
38. Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells.
Droeser RA; Obermann EC; Wolf AM; Wallner S; Wolf D; Tzankov A
Clin Breast Cancer; 2013 Aug; 13(4):264-70. PubMed ID: 23829892
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis.
Feng T; Zhang P; Sun Y; Han X; Tong J; Hua Z
Biomed Res Int; 2020; 2020():1839205. PubMed ID: 32190652
[TBL] [Abstract][Full Text] [Related]
40. FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial.
Ladoire S; Mignot G; Dalban C; Chevriaux A; Arnould L; Rébé C; Apetoh L; Boidot R; Penault-Llorca F; Fumoleau P; Roché H; Spielmann M; Levy C; Lortholary A; Eichler F; Mesleard C; Bonnetain F; Ghiringhelli F
Ann Oncol; 2012 Oct; 23(10):2552-2561. PubMed ID: 22431701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
